Analyzing Nyxoah (NASDAQ:NYXH) & Zepp Health (NYSE:ZEPP)

Nyxoah (NASDAQ:NYXH) and Zepp Health (NYSE:ZEPP) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk and analyst recommendations.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Nyxoah and Zepp Health, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nyxoah	1	0	3	0	2.50
Zepp Health	1	0	1	0	2.00

Nyxoah presently has a consensus price target of $12.67, indicating a potential upside of 181.48%. Zepp Health has a consensus price target of $64.37, indicating a potential upside of 129.56%. Given Nyxoah’s stronger consensus rating and higher probable upside, analysts plainly believe Nyxoah is more favorable than Zepp Health.

Insider and Institutional Ownership

52.6% of Zepp Health shares are owned by institutional investors. 17.1% of Nyxoah shares are owned by company insiders. Comparatively, 36.0% of Zepp Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Volatility and Risk

Nyxoah has a beta of 1.55, indicating that its share price is 55% more volatile than the S&P 500. Comparatively, Zepp Health has a beta of 1.45, indicating that its share price is 45% more volatile than the S&P 500.

Profitability

This table compares Nyxoah and Zepp Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nyxoah	-1,457.97%	-101.99%	-66.74%
Zepp Health	-28.28%	-21.45%	-9.20%

Earnings & Valuation

This table compares Nyxoah and Zepp Health”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nyxoah	$4.89 million	31.34	-$64.10 million	($2.49)	-1.81
Zepp Health	$182.60 million	2.23	-$75.73 million	($4.11)	-6.82

Nyxoah has higher earnings, but lower revenue than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.

Summary

Nyxoah beats Zepp Health on 8 of the 14 factors compared between the two stocks.

About Nyxoah

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

About Zepp Health

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals. The company offers smart bands, watches, modules, and scales; and associated accessories, smart hearable products, sportswear, home fitness equipment, home appliances, and smart watch accessories. It also provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. It offers its products under the Amazfit and Zepp brand names in approximately 90 countries. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.